Sunshine Biopharma News

8-K: SUNSHINE BIOPHARMA REPORTS 2024 FIRST QUARTER RESULTS: REVENUES UP 54%

May 22 16:16 ET

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 15 10:45 ET

8-K: Current report

May 8 16:28 ET

8-K: Current report

May 6 12:19 ET

8-K: Current report

Apr 23 16:11 ET

Sunshine Biopharma | 8-K: Current report

Apr 1 14:32 ET

Sunshine Biopharma | DEF 14C: Definitive information statements

Mar 15 11:16 ET

Sunshine Biopharma | 8-K: Current report

Mar 6 16:12 ET

Sunshine Biopharma | DEF 14C: Definitive information statements

Mar 5 11:40 ET

Sunshine Biopharma | 8-K: Current report

Mar 1 16:25 ET

Sunshine Biopharma | 8-K: Current report

Feb 16 17:03 ET

Sunshine Biopharma | 8-K: Current report

Feb 15 11:42 ET

Sunshine Biopharma | 8-K: Current report

Feb 12 09:09 ET

Sunshine Biopharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Feb 9 17:20 ET

Sunshine Biopharma | S-1: General form for registration of securities under the Securities Act of 1933

Feb 1 16:24 ET

Sunshine Biopharma | 8-K: Current report

Jan 30 12:43 ET

Sunshine Biopharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 8 00:00 ET

Sunshine Biopharma | 8-K: Current report

Dec 7, 2023 16:59 ET

Sunshine Biopharma | 8-K: SUNSHINE BIOPHARMA REPORTS 2023 THIRD QUARTER RESULTS: REVENUES UP SIGNIFICANTLY OVER LAST YEAR DUE TO A KEY ACQUISITION

Nov 13, 2023 09:00 ET

Sunshine Biopharma | 8-K: Current report

Nov 2, 2023 12:18 ET